Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. reports on a corporate action approved by the Board of Directors on April 25, 2022. The filing pertains to the issuance of new common shares resulting from the exercise of stock options under the Company's 2022 Stock Option Plan. The report was signed on April 27, 2022.
Key Financial Metrics
The filing details a capital increase rather than operational financial performance. Key metrics related to the transaction include:
- Capital Increase Amount: BRL 84,368,512.00
- New Capital Stock Total: BRL 58,130,517,165.22
- Shares Issued: 5,550,560 new common shares (no par value)
- Issuance Price: BRL 15.20 per share
- Potential Dilution: 0.035254% (by share count) and 0.145347% (by capital stock)
Operational metrics such as revenue, profit, cash flow, margins, debt, and liquidity are not provided in this filing.
Material Changes
The primary material change is the expansion of the Company's capital stock due to the exercise of stock options by certain beneficiaries. The filing provides historical market price data for the Company's shares over the last three years, two years (quarterly), and six months (monthly), adjusted for interest on own capital and dividend distributions. The average market price over the last 90 days was BRL 14.79.
Guidance, Outlook, and Risks
This filing does not contain management guidance, future outlook, risk factors, contingencies, or commentary on unusual items. It is strictly a notice of a capital increase approved pursuant to Brazilian Law No. 6,404/76 and the Company's Bylaws.
Investor Verification Checklist
- Verify the impact of the 0.035254% share dilution on existing holdings.
- Confirm the total new capital stock value of BRL 58.13 billion.
- Review the issuance price of BRL 15.20 against the 90-day average market price of BRL 14.79.
- Note that this filing does not contain quarterly or annual financial performance data.